Saltar al contenido

Zoetis Inc. (ZTS) stock: revenue, earnings & dividend

Zoetis Inc. (ZTS, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener ZTS · NYSE Pharma & Biotech US-NJ

Key figures

Fiscal year
2025
Revenue
9.47 bn $
Revenue growth
2.3 %
Revenue growth 5y (p.a.)
7.2 %
Net income
2.67 bn $
Net margin
28.2 %
Operating margin
–
Earnings per share (diluted)
6.02 $
Dividend per share
2.03 $
Payout ratio
33.7 %
Consecutive dividend years
13 years
Consecutive dividend raises
12 years
Dividend growth 5y (p.a.)
19 %
Total assets
15.5 bn $
Equity
3.42 bn $
Equity ratio
22.1 %
Return on equity
78.3 %
Cash
2.45 bn $
Operating cash flow
2.9 bn $
Free cash flow
2.28 bn $
Shares outstanding
406,316,147

History

Revenue by fiscal year

2016 4.89 bn $
2017 5.31 bn $
2018 5.83 bn $
2019 6.26 bn $
2020 6.68 bn $
2021 7.78 bn $
2022 8.08 bn $
2023 8.54 bn $
2024 9.26 bn $
2025 9.47 bn $

Net income by fiscal year

2016 821 m $
2017 864 m $
2018 1.43 bn $
2019 1.5 bn $
2020 1.64 bn $
2021 2.04 bn $
2022 2.11 bn $
2023 2.34 bn $
2024 2.49 bn $
2025 2.67 bn $

Dividend per share

2016 0.39 $
2017 0.44 $
2018 0.54 $
2019 0.69 $
2020 0.85 $
2021 1.08 $
2022 1.35 $
2023 1.56 $
2024 1.80 $
2025 2.03 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20259.47 bn $2.67 bn $6.02 $2.03 $2.9 bn $
20249.26 bn $2.49 bn $5.47 $1.80 $2.95 bn $
20238.54 bn $2.34 bn $5.07 $1.56 $2.35 bn $
20228.08 bn $2.11 bn $4.49 $1.35 $1.91 bn $
20217.78 bn $2.04 bn $4.27 $1.08 $2.21 bn $
20206.68 bn $1.64 bn $3.42 $0.85 $2.13 bn $
20196.26 bn $1.5 bn $3.11 $0.69 $1.8 bn $
20185.83 bn $1.43 bn $2.93 $0.54 $1.79 bn $
20175.31 bn $864 m $1.75 $0.44 $1.35 bn $
20164.89 bn $821 m $1.65 $0.39 $713 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)